Health Care & Life Sciences » Pharmaceuticals | Kissei Pharmaceutical Co. Ltd.

Kissei Pharmaceutical Co. Ltd. | Ownership

Companies that own Kissei Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Brandes Investment Partners LP
2,759,900
5.33%
2,759,900
0.61%
06/30/2017
The Vanguard Group, Inc.
739,899
1.43%
-2,300
0%
07/31/2018
Nomura Asset Management Co., Ltd.
612,697
1.18%
18,597
0.01%
07/31/2018
Norges Bank Investment Management
599,100
1.15%
38,059
0%
12/31/2017
Dimensional Fund Advisors LP
517,100
1%
60,900
0%
04/30/2018
Amundi Japan Ltd.
397,296
0.77%
268,297
0.11%
07/31/2018
Schroder Investment Management Ltd.
324,300
0.63%
-15,200
0.01%
06/30/2018
Daiwa Asset Management Co. Ltd.
287,800
0.56%
-12,000
0.01%
07/31/2018
Nikko Asset Management Co., Ltd.
265,198
0.51%
2,698
0.01%
08/20/2018
BlackRock Fund Advisors
165,200
0.32%
0
0%
09/06/2018

About Kissei Pharmaceutical Co.

View Profile
Address
19-48 Yoshino
Matsumoto 399
Japan
Employees -
Website http://www.kissei.co.jp
Updated 07/08/2019
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Ethical Pharmaceuticals and Others. The Ethical Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.